(fra kommisjonsforordningen)

(1) Commission Directive 2008/69/EC included lenacil as an active substance in Annex I to Council Directive 91/414/EEC. 

(2) Active substances included in Annex I to Directive 91/414/EEC are deemed to have been approved under Regulation (EC) No 1107/2009 and are listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011. 

(3) The approval of the active substance lenacil, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 15 August 2025.

(4) An application for the renewal of the approval of the active substance lenacil was submitted to Belgium, the rapporteur Member State, and Austria, the co-rapporteur Member State, in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 and within the time period provided for in that Article. 

(5) The applicant submitted the supplementary dossier required to the rapporteur Member State, the co-rapporteur Member State, the Commission and the European Food Safety Authority (‘the Authority’) in accordance with Article 6 of Implementing Regulation (EU) No 844/2012. The application was found to be admissible by the rapporteur Member State. 

(6) The rapporteur Member State prepared a draft renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the Authority and the Commission on 2 January 2019. In its draft renewal assessment report, the rapporteur Member State proposed to renew the approval of lenacil. 

(7) The Authority made the supplementary summary dossier available to the public. The Authority also circulated the draft renewal assessment report to the applicant and to the Member States for comments and launched a public consultation on it. The Authority forwarded the comments received to the Commission. 

(8) In March 2020, the Authority requested additional information from the applicant on the endocrine disrupting properties of lenacil pursuant to Article 13(3a), first subparagraph, of Implementing Regulation (EU) No 844/2012 to allow the Authority to conclude the assessment as regards whether the scientific criteria for the determination of endocrine disrupting properties set out in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009, as introduced by Commission Regulation (EU) 2018/605, are met. The applicant submitted the requested information to the Authority. 

(9) In May 2023, the rapporteur Member State made an updated draft renewal assesment report available to the Authority, the Member States and the Commission. In its updated draft renewal assessment report, the rapporteur Member State considered the additional information regarding the criteria to identify endocrine disrupting properties and proposed renewing the approval of lenacil. 

(10) On 11 June 2024, the Authority communicated to the Commission its Conclusion indicating that plant protection products containing lenacil can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009, including that lenacil has no endocrine disrupting properties. 

(11) The Commission presented a renewal report and a draft of this Regulation to the Standing Committee on Plants, Animals, Food and Feed on 4 December 2024 and 12 March 2025, respectively. 

(12) The Commission invited the applicant to submit its comments on the Conclusion of the Authority and, in accordance with Article 14(1), third subparagraph, of Implementing Regulation (EU) No 844/2012, on the renewal report. The applicant submitted its comments, which have been carefully examined and taken into consideration. 

(13) It has been established with respect to one or more representative uses of at least one plant protection product containing the active substance lenacil that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied. 

(14) It is therefore appropriate to renew the approval of lenacil. 

(15) In accordance with Article 14(1) of Regulation (EC) No 1107/2009 in conjunction with Article 6 thereof and in the light of current scientific and technical knowledge and the outcome of the risk assessment, it is, however, necessary to provide for certain conditions. In particular, it is necessary to pay attention to the possible need for additional rotational crop field trials and livestock exposure assessment until the required confirmatory information has been assessed by the rapporteur Member State and evaluated by the Authority. Further confirmatory information is required on rotational crops field trials, including analysis for known and possible new metabolites. 

(16) Implementing Regulation (EU) No 540/2011 should be amended accordingly. 

(17) Lenacil had been included in the list of candidates for substitution established in the Annex to Commission Implementing Regulation (EU) 2015/408 as it was considered to be a persistent and toxic substance. An active substance shall be approved as a candidate for substitution pursuant to Article 24 of Regulation (EC) No 1107/2009 where it meets two of the criteria to be considered a persistent, bioaccumulative and toxic (PBT) substance. The risk assessment for the renewal of the approval of lenacil showed that the substance does not meet the criteria to be considered bioaccumulative and toxic substance in accordance with points 3.7.2.2 and 3.7.2.3 of Annex II to Regulation (EC) No 1107/2009, respectively. As two of the three criteria are not met, lenacil should not be considered as a candidate for substitution. It is therefore appropriate to delete the entry for the active substance lenacil in the Annex to Implementing Regulation (EU) 2015/408.

(18) Commission Implementing Regulation (EU) 2023/2592 extended the approval period of lenacil to 15 August 2025 in order to allow the renewal process to be completed before the expiry of the approval period of that active substance. However, given that a decision on the renewal of the approval of lenacil has been taken ahead of that extended expiry date, this Regulation should apply earlier than that date. 

(19) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,